119 related articles for article (PubMed ID: 25472541)
1. Prolactin-induced prostate tumorigenesis.
Sackmann-Sala L; Goffin V
Adv Exp Med Biol; 2015; 846():221-42. PubMed ID: 25472541
[TBL] [Abstract][Full Text] [Related]
2. Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors.
Rouet V; Bogorad RL; Kayser C; Kessal K; Genestie C; Bardier A; Grattan DR; Kelder B; Kopchick JJ; Kelly PA; Goffin V
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15199-204. PubMed ID: 20699217
[TBL] [Abstract][Full Text] [Related]
3. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
[TBL] [Abstract][Full Text] [Related]
4. Prolactin-induced prostate tumorigenesis links sustained Stat5 signaling with the amplification of basal/stem cells and emergence of putative luminal progenitors.
Sackmann-Sala L; Chiche A; Mosquera-Garrote N; Boutillon F; Cordier C; Pourmir I; Pascual-Mathey L; Kessal K; Pigat N; Camparo P; Goffin V
Am J Pathol; 2014 Nov; 184(11):3105-19. PubMed ID: 25193592
[TBL] [Abstract][Full Text] [Related]
5. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
[TBL] [Abstract][Full Text] [Related]
6. PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro.
Ahonen TJ; Härkönen PL; Rui H; Nevalainen MT
Endocrinology; 2002 Jan; 143(1):228-38. PubMed ID: 11751614
[TBL] [Abstract][Full Text] [Related]
7. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade.
Li H; Ahonen TJ; Alanen K; Xie J; LeBaron MJ; Pretlow TG; Ealley EL; Zhang Y; Nurmi M; Singh B; Martikainen PM; Nevalainen MT
Cancer Res; 2004 Jul; 64(14):4774-82. PubMed ID: 15256446
[TBL] [Abstract][Full Text] [Related]
8. STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice.
Boutillon F; Pigat N; Sala LS; Reyes-Gomez E; Moriggl R; Guidotti JE; Goffin V
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31269779
[TBL] [Abstract][Full Text] [Related]
9. Human and murine prostate basal/stem cells are not direct targets of prolactin.
Sackmann-Sala L; Angelergues A; Boutillon F; d'Acremont B; Maidenberg M; Oudard S; Goffin V
Gen Comp Endocrinol; 2015 Sep; 220():133-42. PubMed ID: 25888939
[TBL] [Abstract][Full Text] [Related]
10. Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.
Thomas LN; Merrimen J; Bell DG; Rendon R; Goffin V; Too CK
Prostate; 2014 May; 74(7):732-42. PubMed ID: 24615730
[TBL] [Abstract][Full Text] [Related]
11. Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context.
Gutzman JH; Rugowski DE; Nikolai SE; Schuler LA
Oncogene; 2007 Sep; 26(43):6341-8. PubMed ID: 17438530
[TBL] [Abstract][Full Text] [Related]
12. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
Sakamoto K; Triplett AA; Schuler LA; Wagner KU
Oncogene; 2010 Sep; 29(39):5359-69. PubMed ID: 20639901
[TBL] [Abstract][Full Text] [Related]
13. Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells.
Koirala S; Thomas LN; Too CK
Mol Endocrinol; 2014 Mar; 28(3):331-43. PubMed ID: 24433040
[TBL] [Abstract][Full Text] [Related]
14. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.
Bole-Feysot C; Goffin V; Edery M; Binart N; Kelly PA
Endocr Rev; 1998 Jun; 19(3):225-68. PubMed ID: 9626554
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
16. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
Goffin V
Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
[TBL] [Abstract][Full Text] [Related]
17. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
Nevalainen MT; Xie J; Bubendorf L; Wagner KU; Rui H
Mol Endocrinol; 2002 May; 16(5):1108-24. PubMed ID: 11981045
[TBL] [Abstract][Full Text] [Related]
18. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
Xu X; Kreye E; Kuo CB; Walker AM
Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
[TBL] [Abstract][Full Text] [Related]
19. The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications.
Goffin V; Touraine P
Expert Opin Ther Targets; 2015; 19(9):1229-44. PubMed ID: 26063597
[TBL] [Abstract][Full Text] [Related]
20. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
Selvaraj NG; Omi E; Gibori G; Rao MC
Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
